XML 54 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Segment reporting (Tables)
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes
The following is a summary of segment net revenues, segment operating income (loss), and a reconciliation of segment operating income (loss) to consolidated income before income taxes:
 
Three months ended June 30,
 
Six months ended June 30,
 
2020
 
2019
 
2020
 
2019
Segment revenues:
 
 
 
 
 
 
 
U.S. dialysis
 
 
 
 
 
 
 
Dialysis patient service revenues:
 
 
 
 
 
 
 
External sources
$
2,631,827

 
$
2,601,951

 
$
5,211,067

 
$
5,113,777

Intersegment revenues
35,122

 
30,042

 
67,062

 
60,462

U.S. dialysis patient service revenues
2,666,949

 
2,631,993

 
5,278,129

 
5,174,239

Other revenues(1):
 
 
 
 
 
 
 
External sources
7,688

 
5,209

 
12,830

 
9,893

Intersegment revenues
307

 
292

 
608

 
513

Total U.S. dialysis revenues
2,674,944

 
2,637,494

 
5,291,567

 
5,184,645

Other—Ancillary services
 
 
 
 
 
 
 
Dialysis patient service revenues, net
126,370

 
121,865

 
260,411

 
239,728

Other external sources
114,094

 
113,680

 
236,908

 
222,419

Intersegment revenues
4,171

 
3,403

 
8,324

 
6,739

Total ancillary services revenues
244,635

 
238,948

 
505,643

 
468,886

Total net segment revenues
2,919,579

 
2,876,442

 
5,797,210

 
5,653,531

Elimination of intersegment revenues
(39,600
)
 
(33,737
)
 
(75,994
)
 
(67,714
)
Consolidated revenues
$
2,879,979

 
$
2,842,705

 
$
5,721,216

 
$
5,585,817

Segment operating income (loss):
 

 
 

 
 

 
 

U.S. dialysis
$
522,630

 
$
498,957

 
$
1,014,236

 
$
915,939

Other—Ancillary services
(39,622
)
 
(15,050
)
 
(42,268
)
 
(72,680
)
Total segment operating income
483,008

 
483,907

 
971,968

 
843,259

Reconciliation of segment operating income to consolidated
income from continuing operations before income taxes:
 
 
 
 
 
 
 
Corporate administrative support
(73,088
)
 
(22,021
)
 
(96,672
)
 
(40,866
)
Consolidated operating income
409,920

 
461,886

 
875,296

 
802,393

Debt expense
(81,381
)
 
(131,666
)
 
(169,984
)
 
(263,185
)
Debt prepayment and refinancing charges

 
(12,160
)
 
(2,948
)
 
(12,160
)
Other income, net
9,545

 
5,643

 
5,195

 
12,583

Consolidated income from continuing operations
before income taxes
$
338,084

 
$
323,703

 
$
707,559

 
$
539,631

 
(1)
Includes management fee revenue from providing management and administrative services to dialysis ventures in which the Company owns a noncontrolling equity investment or which are wholly-owned by third parties.
Summary of Assets by Reportable Segment
A summary of assets by reportable segment was as follows:
 
June 30, 2020
 
December 31, 2019
U.S. dialysis (including equity investments of $130,732
 and $124,188, respectively)
$
17,896,917

 
$
15,778,880

Other—Ancillary services (including equity investments
of
$124,757 and $117,795, respectively)
1,408,174

 
1,532,514

Consolidated assets
$
19,305,091

 
$
17,311,394


Summary of Depreciation and Amortization Expense by Reportable Segment
Depreciation and amortization expense by reportable segment was as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2020
 
2019
 
2020
 
2019
U.S. dialysis
$
148,312

 
$
144,621

 
$
294,612

 
$
285,401

OtherAncillary services
9,064

 
7,621

 
17,443

 
15,369

 
$
157,376

 
$
152,242

 
$
312,055

 
$
300,770


Summary of Expenditures for Property and Equipment by Reportable Segment
Expenditures for property and equipment by reportable segment were as follows:
 
Six months ended June 30,
 
2020
 
2019
U.S. dialysis
$
280,801

 
$
319,812

Other—Ancillary services
10,866

 
15,640

DMG—Discontinued operations

 
38,466

 
$
291,667

 
$
373,918